Elicio Therapeutics, Inc. (ELTX) Net income 2020–2025
Elicio Therapeutics, Inc. (ELTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$39.6MFY2025 · since FY2020: -$80.1M → -$39.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.6M | +23.8% |
| FY2024 | -$51.9M | -47.5% |
| FY2023 | -$35.2M | -24.8% |
| FY2022 | -$28.2M | +48.3% |
| FY2021 | -$54.6M | +31.9% |
| FY2020 | -$80.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice